NEKTAR THERAPEUTICS shareholders Q1 2021

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 237 filers reported holding NEKTAR THERAPEUTICS in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

NEKTAR THERAPEUTICS shareholders Q1 2021
NameSharesValueWeighting ↓
Alexandria Capital, LLC 82,220$1,644,0000.17%
Empire Life Investments Inc. 94,163$1,883,0000.13%
Tekla Capital Management LLC 180,438$3,609,0000.12%
PRIVATE ASSET MANAGEMENT INC 40,506$810,0000.11%
FIRST TRUST ADVISORS LP 4,148,080$82,962,0000.10%
MCIA Inc 10,000$187,0000.09%
ROPES WEALTH ADVISORS LLC 23,160$447,0000.08%
Supplemental Annuity Collective Trust of NJ 10,000$200,0000.07%
Vident Investment Advisory, LLC 100,706$2,015,0000.07%
Quantitative Investment Management, LLC 39,828$796,0000.07%
FRONTIER CAPITAL MANAGEMENT CO LLC 445,922$8,918,0000.07%
Bayesian Capital Management, LP 13,769$275,0000.06%
AdvisorNet Financial, Inc 40,000$800,0000.06%
Mercer Capital Advisers, Inc. 5,000$100,0000.05%
NEXPOINT ASSET MANAGEMENT, L.P. 10,000$200,0000.05%
GAM Holding AG 51,403$1,028,0000.05%
Jump Financial, LLC 23,500$470,0000.04%
Candriam S.C.A. 306,085$4,998,0000.04%
GRANDFIELD & DODD, LLC 27,208$540,0000.04%
WELLINGTON MANAGEMENT GROUP LLP 11,383,721$227,674,0000.04%
External links

This page lists NEKTAR THERAPEUTICS's shareholders in Q1 2021. To view NEKTAR THERAPEUTICS's shareholder history, click here.